Vaccines Market worth 48.03 Billion USD by 2021 - Market Dynamics - Key Players Strategies

1. MarketsandMarkets Presents Vaccines Technology Market worth 48.03 Billion USD by 2021 http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

2. The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global market is broadly classified into technology, type, disease indication, end-users, and regions. • On the basis of technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, toxoid vaccines, and recombinant vaccines. The conjugate vaccines segment is expected to account for the largest share of the global market in 2016. Increasing government support for vaccine development and rising company investments will drive the growth of this market segment. • Early buyers will receive 10% customization on reports. http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

3. Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent vaccines segment is expected to account for the largest share of this market. The large share of the market is attributed to rising prevalence of diseases and increasing government and non-government initiatives for vaccine R&D activities. • Disease indications, included in the vaccines market are pneumococcal disease, influenza, diphtheria, tetanus, and pertussis (DTP), hepatitis, rotavirus, varicella, meningococcal disease, polio, measles, mumps, and rubella (MMR), human papilloma virus (HPV) infection, and others. The pneumococcal disease segment is expected to account for the largest share of the global market in 2016. High incidence of pneumococcal infections and the need for immunizations to prevent the disease increases the market growth of this segment. • End-users, included in the vaccines market are paediatrics and adults. The paediatrics segment is expected to account for the largest share of the global market in 2016. Rising number of awareness programs to promote vaccination have resulted in the increasing use of vaccines for paediatrics. http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

4. Market Segmentation • This report categorizes the vaccines market into the following segments: • Vaccines Market, by Product • Conjugate vaccines • Live Attenuated vaccines • Inactivated and Subunit Vaccines • Toxoid vaccines • Recombinant vaccines • Available Customizations • With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report: • Company Information: Detailed company profiles of five or more market players • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

5. Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by government initiatives for immunization against diseases such as influenza and HPV in the North American countries. • The major players in the vaccines market are Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India Pvt. Ltd. (India). • Request Knowledge Store Demo : • http://www.marketsandmarkets.com/Knowledgestore.asp http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

6. Contact Us Mr. RohanMarkets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, IndiaEmail: sales@marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

7. About MarketsandMarkets MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html